CytoStorm
Medical device startup focused on development of extracorporeal blood-purification systems intended for rapid removal of toxins, inflammatory mediators, and harmful metabolites in emergency care settings (drug overdose, hepatic encephalopathy/liver coma, and sepsis). The organization describes technical work on apheresis-based blood processing, adsorption cartridges with hemocompatibility considerations, and an IP strategy covering multiple countries. Leadership profiles indicate experience in device commercialization, regulatory affairs, clinical operations, and manufacturing.
Industries
Nr. of Employees
small (1-50)
CytoStorm
Products
Extracorporeal blood-purification system (adsorption cartridge and apheresis pump)
A system that draws patient blood, separates cellular components from plasma via an apheresis column, directs plasma through an adsorption column to remove toxins and inflammatory mediators, then recombines and returns treated blood components to the patient for use in emergency detoxification.
Extracorporeal blood-purification system (adsorption cartridge and apheresis pump)
A system that draws patient blood, separates cellular components from plasma via an apheresis column, directs plasma through an adsorption column to remove toxins and inflammatory mediators, then recombines and returns treated blood components to the patient for use in emergency detoxification.
Expertise Areas
- Extracorporeal blood purification
- Apheresis workflows
- Medical device R&D for critical care
- Hemocompatible materials and adsorption media
Key Technologies
- Extracorporeal apheresis
- Plasma adsorption
- Hemocompatible cartridge materials
- Blood component separation